Jacob Plieth

Jacob Plieth

Senior Reporter

Jacob has 21 years' experience of writing about healthcare, and joined Vantage in 2012 from Edison Investment Research, where he spent five years as an equity research analyst.

He has also worked at Dow Jones and the Wall Street Journal. A biochemist by training, Jacob has spoken about pharmaceuticals and other topics on the BBC World Service and News 24, as well as contributing to various publications including Investors Chronicle and Mednous.

Vantage logo
Kickstarting ideas
Independent, data-driven daily news and analysis on pharma, biotech and medtech.